In the last trading session, 4.15 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.76. With the company’s per share price at $0.42 changed hands at -$0.09 or -17.09% during last session, the market valuation stood at $7.14M. PSTV’s last price was a discount, traded about -535.71% off its 52-week high of $2.67. The share price had its 52-week low at $0.24, which suggests the last value was 42.86% up since then.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Instantly PSTV was in red as seen at the end of in last trading. With action -36.36%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -63.48%, with the 5-day performance at -36.36% in the red. However, in the 30-day time frame, Plus Therapeutics Inc (NASDAQ:PSTV) is -37.47% down.
Plus Therapeutics Inc (PSTV) estimates and forecasts
Year-over-year growth is forecast to reach -16.51% down from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 1.11M. 4 analysts are of the opinion that Plus Therapeutics Inc’s revenue for the current quarter will be 1.14M. The company’s revenue for the corresponding quarters a year ago was 1.68M and 1.28M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -33.66%. The estimates for the next quarter sales put growth at -11.06%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.51%. The 2025 estimates are for Plus Therapeutics Inc earnings to increase by 57.69%, but the outlook for the next 5-year period is at 49.89% per year.
PSTV Dividends
Plus Therapeutics Inc is expected to release its next quarterly earnings report in June.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 35.04 shares estimated at $14718.0 under it, the former controlled 0.21% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.19% of the shares, roughly 32.54 shares worth around $13667.0.
